Candel Therapeutics, Inc. (CADL) vs Faeth Therapeutics, Inc. (FTH)
A side-by-side comparison of Candel Therapeutics, Inc. and Faeth Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CADL
Candel Therapeutics, Inc.
$10.21HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
FTH
Faeth Therapeutics, Inc.
$26.56HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — CADL vs FTH
growth of $100 · dividends reinvested · last 5yCADL +46.1% (+7.9%/yr)FTH -82.2% (-29.2%/yr)CADL compounded faster over this window
Log scale — wide-divergence pair
CADL FTH
CADL vs FTH: by the numbers
- •CADL is the larger company ($748M vs $685M market cap).
Metrics side by side
Valuation
| Metric | CADL | FTH |
|---|---|---|
| P/B ratio | 5.93 | 3.96 |
Profitability
| Metric | CADL | FTH |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -70.19% | -113.05% |
| ROIC | -36.83% | -110.62% |
Growth (annualized)
| Metric | CADL | FTH |
|---|---|---|
| Total return CAGR (5Y) | -1.42% | -31.75% |
Frequently asked
- How have CADL and FTH total returns compared?
- Over the past 5 years, CADL delivered -1.42% and FTH delivered -31.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.